There is a need to identify new antifungals for the treatment of serious fungal infections. Given an increasing population of immunocompromised individuals, in particular those undergoing treatment for cancer, fungal infections lead to debilitative illnesses and these patients have a high mortality rate.
Keys to Success
Scientists associated with Sano Chemical have the experience and wherewithal that will promote the successful development of occidiofungin.
To achieve an aura of excellence through an unwavering focus on innovation. Innovation does not occur with a single act, nor will it occur with the successful realization of a new idea. In order to achieve our mission we will tirelessly dedicate our energies to consistently evolving new technologies, quickly adapting to new trends in the industry, and developing new and creative methods to bring occidiofungin to the market.